Home » Topics » BioWorld Science

BioWorld Science
RSS

Lilly to collaborate with Redwire on use of in-space manufacturing technology

July 29, 2022

Preclinical data on long-acting PASylated nomacopan for geographic atrophy and dry AMD

July 29, 2022

TMEM218 identified as new disease gene in a wide range of syndromic ciliopathies

July 29, 2022

Uppthera identifies new serine/threonine-protein kinase PLK1 inhibitors

July 29, 2022

New mutant EGFR inhibitors patented by Biocad

July 29, 2022

Evrys Bio discovers proto-oncogene c-Myc degradation inducers

July 29, 2022

New DNA-PK inhibitors presented by XuanZhu Pharma, Xuanzhu (Hainan) Biopharmaceutical

July 29, 2022

Preclinical characterization of [11C]TZ-7774 as PET tracer for RIPK1-related pathological processes

July 29, 2022

Neuron-like cells are glioblastoma's evil mastermind

July 28, 2022

Tonix and KEMRI collaborate to advance TNX-801 as vaccine for monkeypox and smallpox

July 28, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...